Table 4.

Summary of AEs based on number (%) of patients

Adverse events	6th week		p value	12th week		p value
	Myrtle No. (%)	Clindamycin 1% No. (%)		Myrtle No. (%)	Clindamycin 1% No. (%)
Scabbing	10 (20.8%)	9 (18.8%)	1	7 (13.6%)	8 (16.7%)	0.65
Dryness	3 (6.3%)	4 (8.3%)	0.65	3 (6.3%)	5 (10.4%)	0.08
Aggregation	4 (8.4%)	5 (10.4%)	0.73	2 (4.2%)	1 (2.1%)	0.56
Burning	1 (2.1%)	2 (4.2%)	0.31	0 (0%)	1 (2.1%)	0.31
Itching	0 (0%)	1 (2.1%)	0.31	1 (2.1%)	2 (4.2%)	0.31
Edema	0 (0%)	0 (0%)	1	0 (0%)	1 (2.1%)	0.31
Erythema	0 (0%)	0 (0%)	1	0 (0%)	1 (2.1%)	0.31

AE, adverse event.